Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
109.60
+2.74 (2.56%)
At close: Dec 5, 2025, 4:00 PM EST
107.41
-2.19 (-2.00%)
After-hours: Dec 5, 2025, 6:50 PM EST
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.51 billion as of December 5, 2025. Its market cap has increased by 31.55% in one year.
Market Cap
8.51B
Enterprise Value
7.57B
1-Year Change
31.55%
Ranking
Category
Stock Price
$109.60
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.51B, an increase of 969.30%. That is a compound annual growth rate of 72.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.51B | 53.02% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |